Last Updated : February 10, 2025
Details
FilesGeneric Name:
teriflunomide
Project Status:
Complete
Therapeutic Area:
Multiple Sclerosis (MS)
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
SX0752-000
Call for patient/clinician input closed:
NOC Status at Filing:
N/A
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Fee Schedule:
Pending
Indications:
Radiologically Isolated Syndrome (RIS)
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
| Submission received | 11-Jul-24 |
|---|---|
| Review initiated | 12-Jul-24 |
| Expert committee meeting (initial) | 21-Nov-24 |
| Draft recommendation posted for stakeholder feedback | 12-Dec-24 |
| End of feedback period | 03-Jan-25 |
| Final recommendation posted | 04-Feb-25 |
| CADTH review report(s) posted | 29-Jan-25 |
Files
Last Updated : February 10, 2025